These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 2191608)

  • 21. [Vitamin E, antioxidants and atherosclerosis].
    Lecerf JM; Luc G; Fruchart JC
    Rev Med Interne; 1994; 15(10):641-9. PubMed ID: 7800984
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low-density lipoprotein heterogeneity.
    Griffin BA
    Baillieres Clin Endocrinol Metab; 1995 Oct; 9(4):687-703. PubMed ID: 8593120
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipoproteins versus structural glycoproteins: atherosclerosis as an analogue and competitor of normal connective tissue interactions.
    Bowness JM
    Med Hypotheses; 1976; 2(5):200-2. PubMed ID: 184370
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biological autoxidation. II. Cholesterol esters as inert barrier antioxidants. Self-assembly of porous membrane sacs. An hypothesis.
    Kon SH
    Med Hypotheses; 1978; 4(6):559-80. PubMed ID: 748727
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differences in LDL receptor-mediated metabolism of three low density lipoprotein subfractions by human monocyte-derived macrophages: impact on the risk for atherosclerosis.
    de Graaf J; Hendriks JC; Swinkels DW; Demacker PN; Stalenhoef AF
    Artery; 1993; 20(4):201-30. PubMed ID: 8250739
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The role of modified oxidation of low density lipoprotein in pathognesis of atherosclerosis].
    Siennicka A; Zapolska-Downar D
    Postepy Hig Med Dosw; 2003; 57(2):219-37. PubMed ID: 12866357
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Low density lipoprotein (LDL) heterogeneity and atherosclerosis].
    Dejager S; Cohen R; Bruckert E
    Ann Biol Clin (Paris); 1990; 48(3):154-60. PubMed ID: 2191608
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atherogenic, dense low-density lipoproteins. Pathophysiology and new therapeutic approaches.
    Chapman MJ; Guérin M; Bruckert E
    Eur Heart J; 1998 Feb; 19 Suppl A():A24-30. PubMed ID: 9519339
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Serum lipoprotein and atherogenicity--relationship with particle size and composition of low density lipoproteins, and their modifications by oxidation and glycation].
    Takeuchi N; Saheki S
    Rinsho Byori; 1995 Aug; 43(8):753-62. PubMed ID: 7474432
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The low density lipoprotein and low density lipoprotein receptors and their possible importance in the pathogenesis of atherosclerosis.
    Dresel HA; Friedrich EA; Otto I; Waldherr R; Schettler G
    Arzneimittelforschung; 1985; 35(12A):1936-40. PubMed ID: 3913426
    [TBL] [Abstract][Full Text] [Related]  

  • 31.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 32.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.